KPIs & Operating Metrics(New)
Active Registered PatientsAdjusted EbitdaAdjusted Gross Margin Breakdown %Adjusted Gross Margin Breakdown (Annual)Adjusted Gross Margin Breakdown Core Cannabis %Adjusted Gross Profit BreakdownAdjusted Gross Profit Breakdown (Annual)Adjusted Gross Profit Breakdown Core CannabisAsp By End Market (Per Gram)Asp By Product CategoryBiological AssetsBreakdown Of AssetsCannabis Revenue By Product CategoryCannabis Segment Operating StatisticsCannabis Segment Operating Statistics AnnualCannabis Vs Non Cannabis RevenueContractual Obligations AnnualCore Cannabis Revenue BreakdownCore Cannabis Revenue MixCost Of SalesCost Per Gram Medical CannabisDisaggregated Cannabis RevenueExcise TaxesGross Margin By End Market %Gross Margin By Region On Gross Revenue %Gross ProfitGross Profit %Gross Profit By RegionGross Profit By Region (Annually)Gross Revenue By SegmentGross Revenue By Segment %Inventory By SegmentLocal Vs Outsourcing ProductionNon Current Assets By GeographyNon Gaap Profitability AnnualNon Gaap Profitability Annual %OPEX SegregationOutsourced Supply CostProduction Vs SalesProperty, Plant And Equipment (Gross)Purchase CommitmentsPurchase Commitments AnnualRevenue By Business VerticalRevenue By Business Vertical Mix %Revenue By End MarketRevenue By Geography AnnualRevenue By Geography Annual %Revenue By Recognition Of TimingRevenue By Recognition Of Timing %Revenue By Region (Gross) AnnualRevenue By Region (Net)Revenue By Region (Net) %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Revenue (Gross) By Business VerticalRevenue Gross Vs NetRevenue SegregationRevenue Segregation %Sales Volume Kg (Cannabis)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Aurora Cannabis (ACB) Gross Profit (2018 - 2025)

Historic Gross Profit for Aurora Cannabis (ACB) over the last 8 years, with Q4 2025 value amounting to $33.4 million.

  • Aurora Cannabis' Gross Profit fell 3766.7% to $33.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $96.3 million, marking a year-over-year increase of 10544.06%. This contributed to the annual value of $130.7 million for FY2025, which is 3374.52% up from last year.
  • Aurora Cannabis' Gross Profit amounted to $33.4 million in Q4 2025, which was down 3766.7% from $23.5 million recorded in Q3 2025.
  • In the past 5 years, Aurora Cannabis' Gross Profit ranged from a high of $53.6 million in Q4 2024 and a low of -$1.9 billion during Q3 2024
  • In the last 5 years, Aurora Cannabis' Gross Profit had a median value of $18.8 million in 2023 and averaged -$183.8 million.
  • Over the last 5 years, Aurora Cannabis' Gross Profit had its largest YoY gain of 29382.54% in 2023, and its largest YoY loss of 23221533.62% in 2023.
  • Quarter analysis of 5 years shows Aurora Cannabis' Gross Profit stood at $4.4 million in 2021, then crashed by 313.86% to -$9.5 million in 2022, then surged by 293.83% to $18.4 million in 2023, then skyrocketed by 192.33% to $53.6 million in 2024, then plummeted by 37.67% to $33.4 million in 2025.
  • Its Gross Profit stands at $33.4 million for Q4 2025, versus $23.5 million for Q3 2025 and $20.2 million for Q2 2025.